Tag Archives: business

Mass Gift Ban Repeal Efforts Fizzle

By Reid Paul | Published: August 4, 2010
An effort in the Massachusetts legislature to repeal the state’s ban on many gifts to healthcare providers has failed. The year-old ban is considered one of the most restrictive in the country, banning restaurant meals, various gifts and requiring reporting on transfers of value above $50. “This repeal effort was started by legislators concerned that the [...]
Posted in Legal | Also tagged , , , , , , | 1 Comment

Study: Future of Personalized Medicine

By Jeff Schindler | Published: July 27, 2010
An increased focus on targeted medicine has become a staple for all facets of healthcare, from drug developers to consumers to pharma companies. Gerson Lehrman and Bloomberg jointly commissioned a survey that gauged the reactions and predictions of this trend from 52 leading US physicians. The survey covered a number of topics to assess which [...]
Posted in R&D | Also tagged , , , , , , | 1 Comment

Merck to Close Eight Plants

By Oriana Schwindt | Published: July 8, 2010
Image by Getty Images via @daylife Over the next two years, Merck will shut down eight manufacturing plants, as well as eight research sites, as part of the ongoing Schering-Plough merger process. The company said in a statement that the various site exits will help “create a flexible R&D organization.” Taking a page out of Pfizer’s book [...]
Posted in Strategy | Also tagged , , , , , , | 3 Comments

GSK Scores High in Market Access

By George Koroneos | Published: June 23, 2010
GlaxoSmithKline ranked number one in a study of pharmaceutical companies offering access to medicines to emerging and developing nations, proving that the UK drug giant has a far stronger grasp on new markets than its US and Japanese counterparts. The study ranks 20 companies based on significant criteria including pricing, patents and intellectual properties, capacity enhancement, [...]
Posted in Emerging Markets, Strategy | Also tagged , , , , , , | Leave a comment

Takeda Launches New Plan, Cuts US Jobs

By George Koroneos | Published: May 13, 2010
Image via Wikipedia The Japanese are taking a play from the US pharmaceutical industry’s rulebook and restructuring itself under the auspices of a fun catch phrase: “Transformation for a New Takeda.” The punch line, however, isn’t too funny. According to a two-year mid-range plan announced yesterday, Takeda will cut about 1,400 positions in the US to fend off [...]
Posted in Strategy | Also tagged , , , , , , , | Leave a comment